Literature DB >> 15560752

Cleavage at the stem region releases an active ectodomain of the membrane type 1 matrix metalloproteinase.

Marta Toth1, Pamela Osenkowski, Dusan Hesek, Stephen Brown, Samy Meroueh, Wael Sakr, Shahriar Mobashery, Rafael Fridman.   

Abstract

MT1-MMP (membrane type 1 matrix metalloproteinase) is a membrane-anchored MMP that can be shed to the extracellular milieu. In the present study we report the primary structure and activity of the major soluble form of MT1-MMP. MS analysis of the purified 50-kDa soluble MT1-MMP form shows that the enzyme extends from Tyr112 to Val524, indicating that formation of this species requires a proteolytic cleavage within the stem region. In agreement, deletion of the entire stem region of MT1-MMP inhibited shedding of the 50-kDa species. A recombinant 50-kDa species (Tyr112-Val524) expressed in cells exhibited enzymatic activity against pro-MMP-2 and galectin-3, and thus this species is a competent protease. The recombinant 50-kDa soluble form also decreased the level of surface-associated TIMP-2 (tissue inhibitor of metalloproteinase 2) when administered to cells expressing wild-type membrane-anchored MT1-MMP, suggesting that ectodomain shedding of MT1-MMP can alter the MMP/TIMP balance on the cell surface. A approximately 53-kDa species of MT1-MMP was also isolated from a non-detergent extract of human breast carcinoma tissue and was found to lack the cytosolic tail, as determined with specific MT1-MMP domain antibodies. Together, these data show that MT1-MMP ectodomain shedding is a physiological process that may broaden MT1-MMP activity to the pericellular space.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15560752      PMCID: PMC1134979          DOI: 10.1042/BJ20041324

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

Review 1.  Regulation of membrane type-matrix metalloproteinases.

Authors:  Sonia Hernandez-Barrantes; Margarida Bernardo; Marta Toth; Rafael Fridman
Journal:  Semin Cancer Biol       Date:  2002-04       Impact factor: 15.707

2.  Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix.

Authors:  Kevin B Hotary; Edward D Allen; Peter C Brooks; Nabanita S Datta; Michael W Long; Stephen J Weiss
Journal:  Cell       Date:  2003-07-11       Impact factor: 41.582

3.  Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes.

Authors:  Marta Toth; Irina Chvyrkova; M Margarida Bernardo; Sonia Hernandez-Barrantes; Rafael Fridman
Journal:  Biochem Biophys Res Commun       Date:  2003-08-22       Impact factor: 3.575

4.  Complex pattern of membrane type 1 matrix metalloproteinase shedding. Regulation by autocatalytic cells surface inactivation of active enzyme.

Authors:  Marta Toth; Sonia Hernandez-Barrantes; Pamela Osenkowski; M Margarida Bernardo; David C Gervasi; Yoichiro Shimura; Oussama Meroueh; Lakshmi P Kotra; Beatriz G Gálvez; Alicia G Arroyo; Shahriar Mobashery; Rafael Fridman
Journal:  J Biol Chem       Date:  2002-05-09       Impact factor: 5.157

5.  Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase.

Authors:  Elena I Deryugina; Boris I Ratnikov; Tanya I Postnova; Dmitri V Rozanov; Alex Y Strongin
Journal:  J Biol Chem       Date:  2001-11-27       Impact factor: 5.157

6.  Soluble membrane-type 1 matrix metalloproteinase (MT1-MMP) and gelatinase A (MMP-2) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis.

Authors:  Päivi Maisi; Kaiu Prikk; Ruth Sepper; Emma Pirilä; Tuula Salo; Jarkko Hietanen; Timo Sorsa
Journal:  APMIS       Date:  2002-11       Impact factor: 3.205

7.  Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.

Authors:  K Lehti; J Lohi; H Valtanen; J Keski-Oja
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

8.  Membrane type 1-matrix metalloproteinase is activated during migration of human endothelial cells and modulates endothelial motility and matrix remodeling.

Authors:  B G Gálvez; S Matías-Román; J P Albar; F Sánchez-Madrid; A G Arroyo
Journal:  J Biol Chem       Date:  2001-07-11       Impact factor: 5.157

9.  Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage.

Authors:  Eric M Tam; Yi I Wu; Georgina S Butler; M Sharon Stack; Christopher M Overall
Journal:  J Biol Chem       Date:  2002-07-26       Impact factor: 5.157

10.  Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity.

Authors:  T Uekita; Y Itoh; I Yana; H Ohno; M Seiki
Journal:  J Cell Biol       Date:  2001-12-24       Impact factor: 10.539

View more
  12 in total

Review 1.  Probing cellular microenvironments and tissue remodeling by atomic force microscopy.

Authors:  Thomas Ludwig; Robert Kirmse; Kate Poole; Ulrich S Schwarz
Journal:  Pflugers Arch       Date:  2007-12-06       Impact factor: 3.657

Review 2.  Matrix metalloproteinase control of capillary morphogenesis.

Authors:  Cyrus M Ghajar; Steven C George; Andrew J Putnam
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2008       Impact factor: 1.807

3.  Shedding of discoidin domain receptor 1 by membrane-type matrix metalloproteinases.

Authors:  Hsueh-Liang Fu; Anjum Sohail; Rajeshwari R Valiathan; Benjamin D Wasinski; Malika Kumarasiri; Kiran V Mahasenan; M Margarida Bernardo; Dorota Tokmina-Roszyk; Gregg B Fields; Shahriar Mobashery; Rafael Fridman
Journal:  J Biol Chem       Date:  2013-03-21       Impact factor: 5.157

4.  Matrilysin-1 (MMP7) cleaves galectin-3 and inhibits wound healing in intestinal epithelial cells.

Authors:  Manjula Puthenedam; Feng Wu; Alysha Shetye; Alex Michaels; Ki-Jong Rhee; John H Kwon
Journal:  Inflamm Bowel Dis       Date:  2010-09-01       Impact factor: 5.325

Review 5.  MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer.

Authors:  Anjum Sohail; Qing Sun; Huiren Zhao; M Margarida Bernardo; Jin-Ah Cho; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

6.  SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells.

Authors:  Heather M McClung; Stacey L Thomas; Pamela Osenkowski; Marta Toth; Priya Menon; Avraham Raz; Rafael Fridman; Sandra A Rempel
Journal:  Neurosci Lett       Date:  2007-04-21       Impact factor: 3.046

7.  Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding.

Authors:  Georgina S Butler; Richard A Dean; Eric M Tam; Christopher M Overall
Journal:  Mol Cell Biol       Date:  2008-05-27       Impact factor: 4.272

Review 8.  Systems biology of vascular endothelial growth factors.

Authors:  Feilim Mac Gabhann; Aleksander S Popel
Journal:  Microcirculation       Date:  2008-11       Impact factor: 2.628

9.  Matrix metalloproteinases, synaptic injury, and multiple sclerosis.

Authors:  Arek Szklarczyk; Katherine Conant
Journal:  Front Psychiatry       Date:  2010-10-05       Impact factor: 4.157

10.  Conversion of stationary to invasive tumor initiating cells (TICs): role of hypoxia in membrane type 1-matrix metalloproteinase (MT1-MMP) trafficking.

Authors:  Jian Li; Stanley Zucker; Ashleigh Pulkoski-Gross; Cem Kuscu; Mihriban Karaayvaz; Jingfang Ju; Herui Yao; Erwei Song; Jian Cao
Journal:  PLoS One       Date:  2012-06-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.